Search for: "BIOTECH, INC." Results 261 - 280 of 1,249
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Dec 2015, 11:32 am by Beth Mole
Shkreli was arrested on alleged securities fraud related to Retrophin Inc., a biotech firm he founded in 2011. [read post]
29 Nov 2015, 9:54 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
24 Nov 2015, 4:50 am by Simon Lester
The company CEN Biotech Inc. and its co-claimants profess to have suffered a whopping $4.8 billion (US) in damages. [read post]
15 Nov 2015, 9:32 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
8 Nov 2015, 9:20 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
5 Nov 2015, 9:39 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
2 Nov 2015, 6:33 am by Green and Associates
Legal Broadcast Network recently interviewed Los Angeles attorney Tracy Green, and expert in health care regulatory issues, on the possible outcomes of the dispute between Theranos, a $9 billion valued private biotech company started by Elizabeth Holmes, and The Wall Street Journal.Theranos is offering a new technology solution to an old problem. [read post]
1 Nov 2015, 9:57 pm by Patent Docs
Janssen Biotech Inc. et al. v. [read post]
12 Oct 2015, 12:22 am
Lobby groups and technology companies see the advantage of challenging the hold they perceive that large corporations have on controlling markets, especially in the biotech and software areas. [read post]
8 Oct 2015, 9:14 pm by Mark Summerfield
  In particular, all seven High Court judges found that claims 1-3 of Myriad Genetics’ Australian patent no. 686004, each of which is directed to isolated nucleic acid molecules corresponding with the BRCA mutation associated with increased breast cancer risk, are invalid because they do not define a patent-eligible ‘manner of manufacture’ under Australian law: D'Arcy v Myriad Genetics Inc [2015] HCA 35.In arriving at this ruling, the High Court has reversed the… [read post]
4 Oct 2015, 9:08 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
17 Sep 2015, 1:54 pm by David Jensen
 Calabasas is better known for its entertainment personalities, such as the Kardashian family, than biotech. [read post]
13 Sep 2015, 9:21 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
30 Aug 2015, 9:53 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
24 Aug 2015, 9:55 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
18 Aug 2015, 3:30 am by Steve Brachmann
Google recently announced that it would be undergoing a major corporate restructuring, folding itself into a new corporation called Alphabet Inc. [read post]
17 Aug 2015, 7:43 am by David Jensen
 In Oakland, its neighbors will include the FBIand Cerexa, Inc., a biotech firm owned by Forest Laboratories of New York. [read post]
17 Aug 2015, 5:03 am
That means that other parties will not be hindered in developing technologies which also make use of the same judicial exception.Ariosa Diagnostics v SequenomAriosa Diagnostics, Inc. v Sequenom, Inc., No. 2014-1139 (Fed. [read post]
16 Aug 2015, 9:03 pm by Patent Docs
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
9 Aug 2015, 6:03 pm by Kevin LaCroix
In an important decision concerning D&O insurance coverage in connection with failed bank claims, the Tenth Circuit, applying Kansas law, held that a D&O policy’s insured vs. insured exclusion unambiguously precluded coverage for claims brought by the FDIC as receiver of a failed bank against the bank’s former directors and officers. [read post]